Nonetheless, based on the combined results from pyrosequencing (quantitative methylation) and immunohistochemistry (BRCA1 protein expression), we sought to identify germline alterations that might be associated with BRCA1 promoter methylation and correlate with breast cancer risk. The gene discussed is BRCA1; the disease is breast cancer.